Tag results:
breast cancer cells
Mammary Cell News
Hypoxia-Induced lncRNA RBM5-AS1 Promotes Tumorigenesis via Activating Wnt/β-Catenin Signaling in Breast Cancer
[Cell Death & Disease] Overexpression of RBM5-AS1 facilitated proliferation, migration, invasion, EMT, and stemness maintenance of breast cancer cells in vitro and in vivo.
Mammary Cell News
Structural and Morphological Changes of Breast Cancer Cells Induced by Iron(II) Complexes
[Nanoscale] The authors characterized the effects of iron(II)-based complexes on the structural and morphological properties of epithelial non-tumorigenic and tumorigenic breast cell lines using atomic force microscopy, flow cytometry and immunofluorescence microscopy.
Mammary Cell News
Engineer a Pre-Metastatic Niched Microenvironment to Attract Breast Cancer Cells by Utilizing a 3D Printed Polycaprolactone/Nano-Hydroxyapatite Osteogenic Scaffold – an In Vitro Model System...
[Journal of Biomedical Materials Research Part B-Applied Biomaterials] A transwell migration assay was used to investigate recruitment of MDA-MB-231, MCF-7, and MDA-MB-453 breast cancer cells to the osseous polycaprolactone-nano-hydroxyapatite scaffolds.
Mammary Cell News
DNMT1 Facilitates Growth of Breast Cancer by Inducing MEG3 Hyper-Methylation
[Cancer Cell International] Investigators demonstrated that, DNMT1 induced methylation of MEG3 promoter, and played a key role in breast cancer growth throughmiR-494-3p/OTUD4 axis.
Mammary Cell News
SELENOF Is a New Tumor Suppressor in Breast Cancer
[Oncogene] Restoring SELENOF could attenuate a number of aggressive cancer phenotypes in breast cancer cells, including clonogenic survival, and enhance the response to drugs or radiation used in breast cancer therapy.
Mammary Cell News
Targeted Nanoparticle for Co-Delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and...
[Small] A single therapeutic was developed based on trastuzumab-conjugated nanoparticles for co-delivering docetaxel and siRNA against HER2.